The role of inflammation in diabetic retinopathy: a review

S. Taurone, M. Ralli, M. Nebbioso, A. Greco, M. Artico, G. Attanasio, M. Gharbiya, A. M. Plateroti, L. Zamai, A. Micera

Research output: Contribution to journalArticlepeer-review


– OBJECTIVE: Diabetic retinopathy and diabetes represent serious health conditions, being considered among the main causes of blindness. In recent years, anti-VEGF therapies have been of great help in the treatment of retinal pathology and, until now, they represent the primary choice therapy for diabetic retinopathy. Nevertheless, many patients do not experience significant benefits of vision after an anti-VEGF monotherapy. For this reason, several researchers recently focused their attention on the mechanisms that play a central role in the development and progression of diabetic retinopathy. RESULTS: Available scientific evidence confirms that diabetic retinopathy requires other molecules capable of modifying the mechanisms that, together with angiogenesis, contribute to the development of the condition, such as vascular and neuroinflammation. CONCLUSIONS: This review summarizes the current knowledge of the pathological changes that occur in diabetic retinopathy and that might contribute to identify possible new strategies for the treatment of this condition.

Original languageEnglish
Pages (from-to)10319-10329
Number of pages11
JournalEuropean Review for Medical and Pharmacological Sciences
Issue number20
Publication statusPublished - 2020


  • Anti-VEGF therapy
  • Diabetes
  • Diabetic retinopathy
  • Neuroinflammation

ASJC Scopus subject areas

  • Pharmacology (medical)


Dive into the research topics of 'The role of inflammation in diabetic retinopathy: a review'. Together they form a unique fingerprint.

Cite this